Defining the TLT-1 interactome from resting and activated human platelets

Area of Science:

• Immunology
• Hematology
• Proteomics

Background:

• The Triggering Receptor Expressed on Myeloid cells (TREM) family are type I transmembrane proteins crucial for immune responses.
• TREM-like transcript 1 (TLT-1), also known as TREML1, is found in platelets and binds fibrinogen, influencing bleeding during inflammation.

Purpose of the Study:

• To map the TLT-1 interactome in resting and activated human platelets using proteomics.
• To identify novel TLT-1 binding partners and phosphorylation sites involved in platelet signaling.

Main Methods:

• Proteomics screening to identify TLT-1 interactors.
• Co-immunoprecipitation and immunoblotting to validate interactions.
• Analysis of TLT-1 phosphorylation sites.

Main Results:

• Identified several TLT-1 interactors involved in cell adhesion, migration, and platelet activation.
• Confirmed interactions with β3-integrin, RACK1, GRB2, and Rabs 5A, 7, and 11A.
• Discovered novel phosphorylation sites on TLT-1, including a regulated site at Thr280.

Conclusions:

• The study defines the TLT-1 interactome, revealing new signaling pathways in human platelets.
• Identified interactors and phosphorylation sites provide mechanistic insights into TLT-1's role in hemostasis and platelet aggregation.